Expression of the Bcl-2 protein BAD promotes prostate cancer growth
about
Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancerChanges in the transcriptional profile in response to overexpression of the osteopontin-c splice isoform in ovarian (OvCar-3) and prostate (PC-3) cancer cell lines.Syndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancerTargeting proapoptotic protein BAD inhibits survival and self-renewal of cancer stem cellsBAD dephosphorylation and decreased expression of MCL-1 induce rapid apoptosis in prostate cancer cells.BCL-2 family protein, BAD is down-regulated in breast cancer and inhibits cell invasionApoptotic cell signaling in cancer progression and therapyOverexpression of Bcl-2-associated death inhibits A549 cell growth in vitro and in vivo.BAD overexpression inhibits cell growth and induces apoptosis via mitochondrial-dependent pathway in non-small cell lung cancer.Adaptation and clonal selection models of castration-resistant prostate cancer: current perspective.Decreased expression of RPS15A suppresses proliferation of lung cancer cellsLipid catabolism via CPT1 as a therapeutic target for prostate cancer.Exploring the importance of cancer pathways by meta-analysis of differential protein expression networks in three different cancers.Exploiting radiation-induced signaling to increase the susceptibility of resistant cancer cells to targeted drugs: AKT and mTOR inhibitors as an example.Multipronged quantitative proteomic analyses indicate modulation of various signal transduction pathways in human meningiomas.Angiotensin 1-7 modulates molecular and cellular processes central to the pathogenesis of prostate cancer
P2860
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
P248
Q30557008-CD84BF90-3F39-4EFD-BFA3-C58543C3F90FQ33823827-18CDA275-5844-418C-9A81-CDBE3DAF8784Q34177237-9C4F9FFD-7AED-490C-B590-321941B687F9Q34486457-32828208-877A-4AD4-AEF8-2F4B75B253E1Q34990137-022D27C4-CEEC-4D06-BF66-B206437EA6D8Q35006788-5262D65E-E9F9-4D7D-9EB0-860569FA05E9Q35088734-B866736D-F57B-409C-AB44-D12A779444A5Q35831910-691E3F70-B7FD-429E-95BD-BDE9140D4E04Q36908502-8A1E24A6-0729-4662-BCA7-8FCDBA254C61Q38060845-C2E0C175-1B89-480E-887F-58B65A583F65Q38891972-BA1AE0AE-311D-4A7E-A153-B873EBBD7CA7Q38966211-4E1F36AB-25C6-436B-A6EA-4FCB5875014BQ39088214-D8C892F5-6BEA-44B1-8DF9-FBDFF5402B9DQ47960830-4B25A1B2-C79F-45A3-82F9-65749B63D6AFQ48450830-F0A43456-A9E6-4651-921B-0F9151A6EC92Q58563019-A352FDDA-4ED9-48BE-A7D2-9E55D62DEE0E
P2860
Expression of the Bcl-2 protein BAD promotes prostate cancer growth
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Expression of the Bcl-2 protein BAD promotes prostate cancer growth
@ast
Expression of the Bcl-2 protein BAD promotes prostate cancer growth
@en
Expression of the Bcl-2 protein BAD promotes prostate cancer growth
@en-gb
Expression of the Bcl-2 protein BAD promotes prostate cancer growth
@nl
type
label
Expression of the Bcl-2 protein BAD promotes prostate cancer growth
@ast
Expression of the Bcl-2 protein BAD promotes prostate cancer growth
@en
Expression of the Bcl-2 protein BAD promotes prostate cancer growth
@en-gb
Expression of the Bcl-2 protein BAD promotes prostate cancer growth
@nl
prefLabel
Expression of the Bcl-2 protein BAD promotes prostate cancer growth
@ast
Expression of the Bcl-2 protein BAD promotes prostate cancer growth
@en
Expression of the Bcl-2 protein BAD promotes prostate cancer growth
@en-gb
Expression of the Bcl-2 protein BAD promotes prostate cancer growth
@nl
P2093
P2860
P1433
P1476
Expression of the Bcl-2 protein BAD promotes prostate cancer growth
@en
P2093
Adrienne J Smith
George Kulik
Mark Willingham
Ralph D'Agostino
Yelena Karpova
P2860
P356
10.1371/JOURNAL.PONE.0006224
P407
P577
2009-01-01T00:00:00Z